Vaxil BioVXLLF -85.27%38 PEG Ratio is 0.00 as of Jun. 29, 2026. GuruFocus rates VXLLF with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 95 Biotechnology companies, Vaxil Bio ranks better than 98.95% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Vaxil Bio's PE Ratio without NRI is 0.17. Vaxil Bio's 5-Year EBITDA growth rate is 40.20%. Therefore, Vaxil Bio's PEG Ratio for today is 0.00.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Vaxil Bio's PEG Ratio or its related term are showing as below:
VXLLF'
s PEG Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.02
Current: 0.02
During the past 13 years, Vaxil Bio's highest PEG Ratio was 0.02. The lowest was 0.00. And the median was 0.00.
VXLLF's PEG Ratio is ranked better than 98.95% of 95
companies
in the Biotechnology industry
Industry Median: 1.97
vs VXLLF: 0.02
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Vaxil Bio (OTCPK:VXLLF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Vaxil Bio PEG Ratio Related Terms
Vaxil Bio PEG Ratio Historical Data
* Premium members only.
The historical data trend for Vaxil Bio's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Vaxil Bio's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaxil Bio PEG Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vaxil Bio's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Vaxil Bio's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Vaxil Bio (VXLLF) has a PEG Ratio of 0.00 as of Jun. 29, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Vaxil Bio and its competitors. According to the industry distribution chart, Vaxil Bio ranks #1 out of 95 companies in the Biotechnology industry, placing it in the top 1.1%.
Is Vaxil Bio's PEG Ratio too high?
Vaxil Bio's current PEG Ratio is 0.00. Based on the distribution chart, Vaxil Bio ranks #1 out of 95 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vaxil Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Vaxil Bio's PEG Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vaxil Bio ranks #1 out of 95 companies for PEG Ratio. This places Vaxil Bio in the top 1% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Biotechnology company?
The median PEG Ratio among Biotechnology companies is 1.97, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Vaxil Bio and its competitors. For the Biotechnology industry, the median PEG Ratio is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaxil Bio's current PEG Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxil Bio stock overvalued right now?
Vaxil Bio (VXLLF) has a current PEG Ratio of 0.00. The current PEG Ratio is 0.00. Vaxil Bio's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Vaxil Bio (VXLLF), the current PEG Ratio is 0.00 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
38GF Score
Get the complete analysis for VXLLF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VXLLF has been successfully added to your 
